, Volume 68, Issue 4, pp 1361–1367 | Cite as

The in vitro protective effect of salicylic acid against paclitaxel and cisplatin-induced neurotoxicity

  • Damla Cetin
  • Ahmet HacımuftuogluEmail author
  • Abdulgani Tatar
  • Hasan Turkez
  • Basak Togar
Original Article


Paclitaxel (PAC) and cisplatin (CIS) are two established chemotherapeutic drugs used in combination for the treatment of various solid tumors. However, the usage of PAC and CIS are limited because of the incidence of their moderate or severe neurotoxic side effects. In this study, we aimed to assess the protective role of salicylic acid (SA) against neurotoxicity caused by PAC and CIS. For this purpose, newborn Sprague Dawley rats were decapitated in sterile atmosphere and primary cortex neuron cultures were established. On the 10th day SA was added into culture plates. PAC and CIS were added on the 12th day. The cytotoxicity was determined by using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Oxidative alterations were assessed using total antioxidant capacity and total oxidative stress assays in rat primary neuron cell cultures. It was shown that both concentrations of PAC and CIS treatments caused neurotoxicity. Although SA decreased the neurotoxicity by CIS and PAC, it was more effective against the toxicity caused by CIS rather than the toxicity caused by PAC. In conclusion it was clearly revealed that SA decreased the neurotoxic effect of CIS and PAC in vitro.


Paclitaxel Cisplatin Salicylic acid Neurotoxicity Antioxidant capacity Oxidative stress 



This work supported by the Scientific & Technological Research Council of Turkey (TÜBİTAK, Project Number: 107S067).

Conflict of interest

The authors declared that there are no conflicts of interest.


  1. Aydın E, Türkez H, Keleş MS (2014) The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies. Cytotechnology 66:149–157CrossRefGoogle Scholar
  2. Barabas K, Milner R, Lurie D, Adin C (2008) Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 6:1–18CrossRefGoogle Scholar
  3. Cacciatore I, Caccuri AM, Di Stefano A, Luisi G, Nalli M, Pinnen F, Ricci G, Sozio P (2003) Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage. Farmaco 58:787–793CrossRefGoogle Scholar
  4. Cacciatore I, Caccuri AM, Cocco A, De Maria F, Di Stefano A, Luisi G, Pinnen F, Ricci G, Sozio P, Turella P (2005) Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate. Amino Acids 29:255–261CrossRefGoogle Scholar
  5. Chen C, Bai X, Bi Y, Liu G, Li H, Liu Z, Liu H (2015) Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro. Nutr Neurosci. doi: 10.1179/1476830514Y.0000000147
  6. Chentanez V, Thanomsridejchai N, Duangmardphon N, Agthong S, Kaewsema A, Huanmanop T, Maneesri S (2009) Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats. J Med Assoc Thai 92:50–57Google Scholar
  7. Cingolani GM, Di Stefano A, Mosciatti B, Napolitani F, Giorgioni G, Ricciutelli M, Claudi F (2000) Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-dopa. Bioorg Med Chem Lett 10:1385–1388CrossRefGoogle Scholar
  8. Colak S, Geyikoǧlu F, Keles ON, Turkez H, Topal A, Unal B (2011) The neuroprotective role of boric acid on aluminum chloride-induced neurotoxicity. Toxicol Ind Health 27:700–710CrossRefGoogle Scholar
  9. Daikhin Y, Yudkoff M (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130:1026–1031Google Scholar
  10. Dirican E, Turkez H (2014) In vitro studies on protective effect of Glycyrrhiza glabra root extracts against cadmium-induced genetic and oxidative damage in human lymphocytes. Cytotechnology 66:9–16CrossRefGoogle Scholar
  11. Di Stefano A, D’Aurizio E, Trubiani O, Grande R, Di Campli E, Di Giulio M, Di Bartolomeo S, Sozio P, Iannitelli A, Nostro A, Cellini L (2009) Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms. Microb Biotechnol 2:634–641CrossRefGoogle Scholar
  12. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285CrossRefGoogle Scholar
  13. Feghali JG, Liu W, Van De Water TR (2001) L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147–1155CrossRefGoogle Scholar
  14. Ferger B, Teismann P, Earl CD, Kuschinsky K, Oertel WH (1999) Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice. Naunyn Schmiedebergs Arch Pharmacol 360:256–261CrossRefGoogle Scholar
  15. Geyikoglu F, Turkez H (2008) Boron compounds reduce vanadium tetraoxide genotoxicity in human lymphocytes. Environ Toxicol Pharmacol 26:342–347CrossRefGoogle Scholar
  16. Gören B, Mimbay Z, Bilici N, Zarifoğlu M, Oğul E, Korfali E (2009) Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model. Turk Neurosurg 19:230–236Google Scholar
  17. Gornstein E, Schwarz TL (2014) The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions. Neuropharmacology 76:175–183CrossRefGoogle Scholar
  18. Hassan HA, Edrees GM, El-Gamel EM, El-Sayed EA (2014) Amelioration of cisplatin-induced nephrotoxicity by grape seed extract and fish oil is mediated by lowering oxidative stress and DNA damage. Cytotechnology 66:419–429CrossRefGoogle Scholar
  19. Heuking S, Iannitelli A, Di Stefano A, Borchard G (2009) Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination. Inter J Pharmaceut 381:97–105CrossRefGoogle Scholar
  20. Hospers GA, Eisenhauer EA, de Vries EG (1999) The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects. Br J Cancer 80:629–638CrossRefGoogle Scholar
  21. Huang GC, Liu SY, Lin MH, Kuo YY, Liu YC (2004) The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma. Jpn J Clin Oncol 34:499–504CrossRefGoogle Scholar
  22. Jekunen AP, Christen RD, Shalinsky DR, Howell SB (1994) Synergistic interaction between cisplatin and taxol in human ovarian-carcinoma cells in-vitro. Br J Cancer 69:299–306CrossRefGoogle Scholar
  23. Kamisli S, Ciftci O, Cetin A, Kaya K, Kamisli O, Celik H (2014) Fish oil protects the peripheral and central nervous systems against cisplatin-induced neurotoxicity. Nutr Neurosci 17:116–126CrossRefGoogle Scholar
  24. Karpińska A, Gromadzka G (2013) Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies. Postepy Hig Med Dosw 6 67:43–53CrossRefGoogle Scholar
  25. Kusano C, Ferrari B (2008) Total antioxidant capacity: a biomarker in biomedical and nutritional studies. J Cell Mol Biol 7:1–15Google Scholar
  26. Mao-Ying QL, Kavelaars A, Krukowski K, Huo XJ, Zhou W, Price TJ, Cleeland C, Heijnen CJ (2014) The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One 9:e100701CrossRefGoogle Scholar
  27. Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H (2007) Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609–621CrossRefGoogle Scholar
  28. Minami SB, Sha SH, Schacht J (2004) Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res 198:137–143CrossRefGoogle Scholar
  29. Mohanakumar KP, Muralikrishnan D, Thomas B (2000) Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. Brain Res 864:281–290CrossRefGoogle Scholar
  30. Openshaw H, Beamon K, Synold TW, Longmate J, Slatkin NE, Doroshow JH, Forman S, Margolin K, Morgan R, Shibata S, Somlo G (2004) Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine. Clin Cancer Res 10:461–467CrossRefGoogle Scholar
  31. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G (2003) Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin Cancer Res 9:5756–5767Google Scholar
  32. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, Pu YS (2005) Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 65:8455–8460CrossRefGoogle Scholar
  33. Rick O, Beyer J, Schwella N, Schubart H, Schleicher J, Siegert W (2001) Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor. Ann Oncol 12:1151–1155CrossRefGoogle Scholar
  34. Rispoli V, Rotiroti D, Carelli V, Liberatore F, Scipione L, Marra R, Giorgioni G, Di Stefano A (2004) Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert. Neurosci Lett 356:199–202CrossRefGoogle Scholar
  35. Rivas-San Vicente M, Plasencia J (2011) Salicylic acid beyond defence: its role in plant growth and development. J Exp Bot 62:3321–3338CrossRefGoogle Scholar
  36. Rovini A, Carré M, Bordet T, Pruss RM, Braguer D (2010) Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. Biochem Pharmacol 80:884–894CrossRefGoogle Scholar
  37. Shabana YM, Abdel-Fattah GM, Ismail AE, Rashad YM (2008) Control of brown spot pathogen of rice (Bipolaris oryzae) using some phenolic antioxidants. Braz J Microbiol 39:438–444CrossRefGoogle Scholar
  38. Song W, Tang Z, Li M, Lv S, Sun H, Deng M, Liu H, Chen X (2014) Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects. Acta Biomater 10:1392–1402CrossRefGoogle Scholar
  39. Sozio P, D’Aurizio E, Iannitelli A, Cataldi A, Zara S, Cantalamessa F, Nasuti C, Di Stefano A (2010) Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity. Arch Pharm 343:133–142CrossRefGoogle Scholar
  40. Togar B, Turkez H, Tatar A, Hacimuftuoglu A, Geyikoglu F (2014) Cytotoxicity and genotoxicity of zingiberene on different neuron cell lines in vitro. Cytotechnology. doi:  10.1007/s10616-014-9729-9
  41. Turkez H, Geyikoglu F (2011) The efficiacy of bismuth subnitrate against genotoxicity and oxidative stress induced by aluminum sulphate. Toxicol Ind Health 27:133–142CrossRefGoogle Scholar
  42. Turkez H, Tatar A, Hacimuftuoglu A, Ozdemir E (2010) Boric acid as a protector against paclitaxel genotoxicity. Acta Biochim Pol 57:95–97Google Scholar
  43. Turkez H, Geyikoglu F, Yousef MI, Celik K, Bakir TO (2012a) Ameliorative effect of supplementation with l-glutamine on oxidative stress, DNA damage, cell viability and hepatotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat hepatocyte cultures. Cytotechnology 64:687–699CrossRefGoogle Scholar
  44. Turkez H, Geyikoglu F, Mokhtar YI, Togar B (2012b) Eicosapentaenoic acid protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin- induced hepatic toxicity in cultured rat hepatocytes. Cytotechnology 64:15–25CrossRefGoogle Scholar
  45. Turkez H, Celik K, Toğar B (2014) Effects of copaene, a tricyclic sesquiterpene, on human lymphocytes cells in vitro. Cytotechnology 66:597–603CrossRefGoogle Scholar
  46. Van den Berg JH, Beijnen JH, Balm AJ, Schellens JH (2006) Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev 32:390–397CrossRefGoogle Scholar
  47. Vlot AC, Dempsey DA, Klessig DF (2009) Salicylic acid, a multifaceted hormone to combat disease. Annu Rev Phytopathol 47:177–206CrossRefGoogle Scholar
  48. Wang Y, Wang M, Qi H, Pan P, Hou T, Li J, He G, Zhang H (2014) Pathway-dependent inhibition of paclitaxel hydroxylation by kinase inhibitors and assessment of drug-drug interaction potentials. Drug Metab Dispos 42:782–795CrossRefGoogle Scholar
  49. Xue LJ, Guo W, Yuan Y, Anino EO, Nyamdari B, Wilson MC, Frost CJ, Chen HY, Babst BA, Harding SA, Tsai CJ (2013) Constitutively elevated salicylic acid levels alter photosynthesis and oxidative state but not growth in transgenic populus. Plant Cell 25:2714–2730CrossRefGoogle Scholar
  50. Zhang H, Mizumachi T, Carcel-Trullols J, Li L, Naito A, Spencer HJ, Spring PM, Smoller BR, Watson AJ, Margison GP, Higuchi M, Fan CY (2007) Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis 28:1629–1637CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Damla Cetin
    • 1
  • Ahmet Hacımuftuoglu
    • 2
    Email author
  • Abdulgani Tatar
    • 3
  • Hasan Turkez
    • 4
    • 5
  • Basak Togar
    • 6
  1. 1.Department of Medical Pharmacology, Faculty of MedicineKafkas UniversityKarsTurkey
  2. 2.Department of Medical Pharmacology, Faculty of MedicineAtatürk UniversityErzurumTurkey
  3. 3.Department of Medical Genetics, Faculty of MedicineAtatürk UniversityErzurumTurkey
  4. 4.Department of Molecular Biology and Genetics, Faculty of SciencesErzurum Technical UniversityErzurumTurkey
  5. 5.Department of PharmacyUniversity “G. d’Annunzio” Chieti-PescaraChietiItaly
  6. 6.Department of Biology, Faculty of ScienceAtatürk UniversityErzurumTurkey

Personalised recommendations